Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin in Black/African American Patients with Type 2 Diabetes
NCT01194830Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Boehringer Ingelheim. Started Sep 2010; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01194830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194830.